British Journal of Clinical Pharmacology

Publisher
Wiley-Blackwell
Country
United Kingdom
History
1974–present
Impact factor
3.246 (2009)

Some content from Wikipedia, licensed under CC BY-SA

No evidence that doping enhances athletic performance

(HealthDay)—Although use of recombinant human erythropoietin (rHuEPO) is prohibited among athletes because it reportedly enhances performance, there is no scientific evidence that it does so, according ...

Medications created Dec 10, 2012 | popularity not rated yet | comments 0

EPO doping in elite cycling: No evidence of benefit, but high risk of harm

The drug erythropoietin, often called EPO, is banned from sports because it is believed to enhance an athlete's performance and give people who use it an unfair advantage over unenhanced competitors. However a new systemic ...

Health created Dec 05, 2012 | popularity not rated yet | comments 0

Sustained release naltrexone effective, safe for opioid users

(HealthDay)—Sustained release technologies for administering the opioid antagonist naltrexone (SRX) seem to be effective with an acceptable adverse event profile, according to a review published online ...

Medications created Nov 01, 2012 | popularity not rated yet | comments 0

Antidepressants, sleeping pills and anxiety drugs may increase driving risk

Drugs prescribed to treat anxiety, depression and insomnia may increase patients' risk of being involved in motor vehicle accidents, according to a recent study, published in the British Journal of Clinical Pharmacology. Based ...

Medications created Sep 12, 2012 | popularity not rated yet | comments 1

Low-dose duloxetine deemed safe for urinary incontinence

(HealthDay) -- Duloxetine appears safe for the routine clinical care of women with stress urinary incontinence (SUI), according to a study published online July 23 in the British Journal of Clinical Pharmacology.

Diseases, Conditions, Syndromes created Jul 27, 2012 | popularity 5 / 5 (1) | comments 0

Anti-HTN drugs have distinct effect on central, brachial SBP

(HealthDay) -- A reduction in central to brachial amplification induced by some antihypertensive drugs may result in lesser reductions in central than brachial systolic blood pressure, according to research ...

Medical research created Jun 06, 2012 | popularity not rated yet | comments 0

Antidepressant use during pregnancy and high blood pressure

Use of selective serotonin re-uptake inhibitor (SSRI) antidepressants during pregnancy appears to be linked with increased risk of pregnancy induced high blood pressure ("hypertension"), but a causal link has not been established.

Cardiology created Mar 22, 2012 | popularity not rated yet | comments 0 | with audio podcast

Nursing home residents with dementia: Antidepressants are associated with increased risk of falling

Nursing home residents with dementia who use average doses of selective serotonin reuptake inhibitors (SSRIs) are three times more likely to have an injurious fall than similar people who don't use these drugs. The association ...

Health created Jan 19, 2012 | popularity 1 / 5 (1) | comments 1

New hi-tech survey accelerates collection of vaccination data

New technology now makes it possible to collect 'near real-time' data about whether people are having any side effects from vaccination. By studying people who received the 2009-10 swine flu vaccination in Scotland, researchers ...

Medications created Nov 15, 2011 | popularity not rated yet | comments 0